Prendergast, M., Rogers, D., Barron, S., Bardo, M., & Littleton, J. (2002). Ethanol and nicotine: a pharmacologic balancing act? Alcoholism, Clinical and Experimental Research, 26(12), 1917-8. https://doi.org/10.1097/01.ALC.0000040846.27378.80

Harris, B., Prendergast, M., Gibson, D., Rogers, D., Blanchard, J., Holley, R., … Littleton, J. (2002). Acamprosate inhibits the binding and neurotoxic effects of trans-ACPD, suggesting a novel site of action at metabotropic glutamate receptors. Alcoholism, Clinical and Experimental Research, 26(12), 1779-93. https://doi.org/10.1097/01.ALC.0000042011.99580.98

Prendergast, M., Rogers, D., Mulholland, P., Littleton, J., LH, W. , Jr, Self, R., & Nath, A. (2002). Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitive-site on the N-methyl-D-aspartate receptor. Brain Research, 954(2), 300-7. https://doi.org/10.1016/s0006-8993(02)03360-7 (Original work published 2002)

Kelley, Z., Rogers, D., Littleton, J., & Lynn, B. (2019). Microfluidic capillary zone electrophoresis mass spectrometry analysis of alkaloids in Lobelia cardinalis transgenic and mutant plant cell cultures. Electrophoresis, 40(22), 2921-2928. https://doi.org/10.1002/elps.201900220

Khan, M., Ghanim, R., Kiser, M., Moradipour, M., Rogers, D., Littleton, J., … Knutson, B. (2022). Strategy for Conjugating Oligopeptides to Mesoporous Silica Nanoparticles Using Diazirine-Based Heterobifunctional Linkers. Nanomaterials (Basel, Switzerland), 12(4). https://doi.org/10.3390/nano12040608 (Original work published 2022)